Back to Stocks
Stock detail
Vertex Pharmaceuticals Incorporated
VRTXSTOCKS | US | NASDAQ | Healthcare | Biotechnology
Profile snapshotUSD 490.4Market cap USD 124.5B
No local candle data found.
Recent detected patterns / setups
Latest 10 Market Radar results for this symbol.
PatternTFDetectedQuality
BullishFVG Reaction Setup15M + 15M28 Jul 26, 15:4575
BullishOrder Block Setup15M28 Jul 26, 15:4577
BullishOliver Kell Momentum Setup15M28 Jul 26, 15:4583
BullishFVG Reaction Setup15M + 15M28 Jul 26, 15:4575
BullishOrder Block Setup15M28 Jul 26, 15:4577
BullishOliver Kell Momentum Setup15M28 Jul 26, 15:4583
BullishFVG Reaction Setup4H + 15M28 Jul 26, 15:4574
BullishOrder Block Setup4H28 Jul 26, 13:3079
BullishFVG Reaction Setup4H + 15M28 Jul 26, 15:4574
BullishOrder Block Setup4H28 Jul 26, 13:3079
Annual
Annual fundamentals
2025 vs previous annual period
Metric202020212022202320242025
Total revenueUSD 6.2B+49.1%USD 7.6B+22.1%USD 8.9B+17.9%USD 9.9B+10.5%USD 11B+11.7%USD 12.1B+9.6%
Net incomeUSD 2.7B+130.4%USD 2.3B-13.6%USD 3.3B+41.8%USD 3.6B+9.0%USD -535.6M-114.8%USD 4B+838.1%
Net profit margin43.7%+54.6%30.9%-29.2%37.2%+20.3%36.7%-1.4%-4.9%-113.3%32.7%+773.6%
EPS10.44+127.9%9.09-12.9%12.97+42.7%14.05+8.3%-2.08-114.8%15.46+843.3%
Quarterly
Quarterly fundamentals
Q1 2026 vs same quarter previous year
MetricQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026
Total revenueUSD 2.9B+15.7%USD 2.8B+3.1%USD 3B+12.1%USD 3.1B+11.0%USD 3.2B+10.8%USD 3B+7.8%
Net incomeUSD 913M-5.8%USD 646.3M-41.2%USD 1B+128.7%USD 1.1B+3.6%USD 1.2B+30.5%USD 1B+59.6%
Net profit margin31.4%-18.5%23.3%-43.0%34.8%+125.6%35.2%-6.7%36.9%+17.7%34.5%+48.0%
EPS3.55-5.6%2.52-40.8%4.02+128.9%4.24+4.7%4.69+32.1%4.06+61.1%
Ownership
Institutional ownership summary
2026 Q2, quarter ended 2026-06-30
PeriodOwnershipInstitutions13F sharesTotal investedPositionsPut/call
2026 Q22026-06-30